Although drug-eluting stents (DES) are more effective than bare-metal stent (BMS) in reducing restenosis rate, there is the need for a prolonged dual antiplatelet therapy. Furthermore, concerns ...

To date, four major clinical trials have demonstrated the sirolimus-eluting stent to be safe and effective in preventing restenosis in ... DESs as opposed to bare-metal stents will also be discussed.

and bare metal stents (BMS) in treating advanced atherosclerotic lesions in the common iliac artery. The results showed no significant difference in the rates of restenosis (re-narrowing of the ...

result in more deaths than bare-metal stents (BMSs). The analysis included 6,033 patients implanted with DESs, and 13,738 patients fitted with BMSs, during 2003 and 2004. Over a 3-year period ...